19 August 2009: NorDiag ASA invites to a presentation of the results on August 26 2009 at 8:30am at Thon Hotel Vika Atrium, Munkedamsveien 45, Oslo.

Please confirm your participation to elin.flo@nordiag.com or by calling +47 970 62 885. Shareholders who wish to receive the quarterly report by mail are requested to send an email regarding this to the same email address.

Representatives from the Company will be CEO Mårten Wigstøl and CFO Tone Kvåle.

The report and the presentation will be published on NorDiag's homepage www.nordiag.com.

Contact:        CFO Tone Kvåle, phone +47 915 19576.

About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and tests), for sample preparation of bacterial and human DNA from difficult biological samples. DNA diagnostics give a more rapid and precise answer, and are the fastest growing market within diagnostics. The Company's applications are today used in connection with STI, Tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo - Norway. The Company has offices and laboratories in Stockholm - Sweden, West Chester (PA) - USA and Vienna - Austria. The group has today 40,1 man years. NorDiag is listed on Oslo Stock Exchange with the ticker NORD. For further information - www.nordiag.com.

Read the notice in Norwegian here